KYBELLA™ is the first and only FDA-approved injectable drug that contours and improves the appearance of submental fullness.
The number of injections and the number of treatments should be tailored to the individual patient’s submental fat distribution and treatment goals. Once the aesthetic response is achieved with KYBELLA™, retreatment is not expected
KYBELLA™ is supplied in a pack of 4 single patient use 2 mL vials. KYBELLA™ is administered by subcutaneous injections into submental fat in approximately 0.2 mL per injection spaced 1 cm apart using a 30G or smaller needle.